<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30064445</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jul</Month><Day>31</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.</ArticleTitle><Pagination><StartPage>116</StartPage><MedlinePgn>116</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">116</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-018-1023-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Enterovirus 71 (EV71) is one of the major causative agents of hand, foot, and mouth disease (HFMD), which is sometimes associated with severe central nervous system disease in children. There is currently no specific medication for EV71 infection. Quercetin, one of the most widely distributed flavonoids in plants, has been demonstrated to inhibit various viral infections. However, investigation of the anti-EV71 mechanism has not been reported to date.</AbstractText><AbstractText Label="METHODS">The anti-EV71 activity of quercetin was evaluated by phenotype screening, determining the cytopathic effect (CPE) and EV71-induced cells apoptosis. The effects on EV71 replication were evaluated further by determining virus yield, viral RNA synthesis and protein expression, respectively. The mechanism of action against EV71 was determined from the effective stage and time-of-addition assays. The possible inhibitory functions of quercetin via viral 2Apro, 3C<sup>pro</sup> or 3D<sup>pol</sup> were tested. The interaction between EV71 3C<sup>pro</sup> and quercetin was predicted and calculated by molecular docking.</AbstractText><AbstractText Label="RESULTS">Quercetin inhibited EV71-mediated cytopathogenic effects, reduced EV71 progeny yields, and prevented EV71-induced apoptosis with low cytotoxicity. Investigation of the underlying mechanism of action revealed that quercetin exhibited a preventive effect against EV71 infection and inhibited viral adsorption. Moreover, quercetin mediated its powerful therapeutic effects primarily by blocking the early post-attachment stage of viral infection. Further experiments demonstrated that quercetin potently inhibited the activity of the EV71 protease, 3C<sup>pro</sup>, blocking viral replication, but not the activity of the protease, 2A<sup>pro</sup>, or the RNA polymerase, 3D<sup>pol</sup>. Modeling of the molecular binding of the 3C<sup>pro</sup>-quercetin complex revealed that quercetin was predicted to insert into the substrate-binding pocket of EV71 3C<sup>pro</sup>, blocking substrate recognition and thereby inhibiting EV71 3C<sup>pro</sup> activity.</AbstractText><AbstractText Label="CONCLUSIONS">Quercetin can effectively prevent EV71-induced cell injury with low toxicity to host cells. Quercetin may act in more than one way to deter viral infection, exhibiting some preventive and a powerful therapeutic effect against EV71. Further, quercetin potently inhibits EV71 3C<sup>pro</sup> activity, thereby blocking EV71 replication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Chenguang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xi</LastName><ForeName>Caili</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Kanghong</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Wa</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Xiaofeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Merck Stiftungsprofessur Molekulare BiotechnologieInstitut f&#xfc;r Molekulare Biowissenschaften Goethe Universit&#xe4;t Frankfurt, 60438, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Jinlan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Shiyun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Canghao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yanhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, Hubei University of Technology, Wuhan, 430068, China. weiyanhong925@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>31400153</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>BSQD2015004</GrantID><Agency>Doctoral Scientific Research Foundation of Hubei University of Technology</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9IKM0I5T1E</RegistryNumber><NameOfSubstance UI="D011794">Quercetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011794" MajorTopicYN="N">Quercetin</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="N">Virus Attachment</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3C protease(3Cpro)</Keyword><Keyword MajorTopicYN="N">Anti-viral activity</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Quercetin</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30064445</ArticleId><ArticleId IdType="pmc">PMC6069798</ArticleId><ArticleId IdType="doi">10.1186/s12985-018-1023-6</ArticleId><ArticleId IdType="pii">10.1186/s12985-018-1023-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhmadishina LV, Eremeeva TP, Trotsenko OE, Ivanova OE, Mikhailov MI, Lukashev AN. Seroepidemiology and molecular epidemiology of enterovirus 71 in Russia. PLoS One. 2014;9:e97404. doi: 10.1371/journal.pone.0097404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0097404</ArticleId><ArticleId IdType="pmc">PMC4018281</ArticleId><ArticleId IdType="pubmed">24819617</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Sumi A, Toyoda S, Hu Q, Zhou D, Mise K, Zhao J, Kobayashi N. Time series analysis of reported cases of hand, foot, and mouth disease from 2010 to 2013 in Wuhan, China. BMC Infect Dis. 2015;15:495. doi: 10.1186/s12879-015-1233-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-1233-0</ArticleId><ArticleId IdType="pmc">PMC4630926</ArticleId><ArticleId IdType="pubmed">26530702</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding NZ, Wang XM, Sun SW, Song Q, Li SN, He CQ. Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. Virus Res. 2009;145:157&#x2013;161. doi: 10.1016/j.virusres.2009.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2009.06.006</ArticleId><ArticleId IdType="pubmed">19540282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BI, Ki H, Park S, Cho E, Chun BC. Effect of climatic factors on hand, foot, and mouth disease in South Korea, 2010-2013. PLoS One. 2016;11:e157500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4902224</ArticleId><ArticleId IdType="pubmed">27285850</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Aoki Y, Matoba Y, Yahagi K, Itagaki T, Katsushima F, Katsushima Y, Ito S, Hongo S, Matsuzaki Y. Molecular epidemiology of enterovirus 71 strains isolated from children in Yamagata, Japan, between 1990 and 2013. J Med Microbio. 2014;63:1356&#x2013;1362. doi: 10.1099/jmm.0.079699-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.079699-0</ArticleId><ArticleId IdType="pubmed">25053796</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Li ML, Hung CT, Shih SR. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 2009;5:e1000593. doi: 10.1371/journal.ppat.1000593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000593</ArticleId><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KY. Enterovirus 71 infection and neurological complications. Korean J Pediatr. 2016;59:395&#x2013;401. doi: 10.3345/kjp.2016.59.10.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2016.59.10.395</ArticleId><ArticleId IdType="pmc">PMC5099286</ArticleId><ArticleId IdType="pubmed">27826325</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Xu M, Yin Z. Antiviral drug discovery for the treatment of enterovirus 71 infections. Antivir Res. 2013;97:183&#x2013;194. doi: 10.1016/j.antiviral.2012.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.005</ArticleId><ArticleId IdType="pubmed">23261847</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert Rev Vaccines. 2016;15:599&#x2013;606. doi: 10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Niu Y, Wang C, Zhang H, Xie B, Xu F, Jin H, Peng Y, Liang L, Xu P. Discovery of 3-benzyl-1,3-benzoxazine-2,4-dione analogues as allosteric mitogen-activated kinase kinase (MEK) inhibitors and anti-enterovirus 71 (EV71) agents. Bioorg Med Chem. 2016;24:3472&#x2013;3482. doi: 10.1016/j.bmc.2016.05.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2016.05.055</ArticleId><ArticleId IdType="pubmed">27288186</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JF, Zhang RS, Ou XH, Chen FM, Sun BC. The role of enterovirus 71 and coxsackievirus a strains in a large outbreak of hand, foot, and mouth disease in 2012 in Changsha, China. Int J Infect Dis. 2014;28:17&#x2013;25. doi: 10.1016/j.ijid.2014.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2014.07.024</ArticleId><ArticleId IdType="pubmed">25236389</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, Qi J. Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbio. 2009;47:2351&#x2013;2352. doi: 10.1128/JCM.00563-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00563-09</ArticleId><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, El KN, Tu S, Ren P, Xu S, Zhu Q, Mo X, Pu D, Wang X, Altmeyer R. Seroepidemiology of enterovirus 71 infection prior to the 2011 season in children in shanghai. J Clin Virol. 2012;53:285&#x2013;289. doi: 10.1016/j.jcv.2011.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.12.025</ArticleId><ArticleId IdType="pubmed">22265829</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Cao L, Zhai Y, Ma J, Nie Q, Li T, Yin Z, Sun Y, Shang L. Inhibition of enterovirus 71 replication by an alpha-hydroxy-nitrile derivative NK-1.9k. Antivir Res. 2017;141:91&#x2013;100. doi: 10.1016/j.antiviral.2017.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.01.002</ArticleId><ArticleId IdType="pubmed">28063993</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZH, Li CM, Ling P, Shen FH, Chen SH, Liu CC, Yu CK, Chen SH. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis. 2008;197:854&#x2013;857. doi: 10.1086/527326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/527326</ArticleId><ArticleId IdType="pmc">PMC7109938</ArticleId><ArticleId IdType="pubmed">18279075</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear DC, Tull TM, Seipel ME, Groarke JM. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother. 1999;43:2109&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89431</ArticleId><ArticleId IdType="pubmed">10471549</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Song Z, Qin B, Zhang X, Chen L, Hu Y, Yuan Z. Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model. Antivir Res. 2013;97:264&#x2013;269. doi: 10.1016/j.antiviral.2012.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.029</ArticleId><ArticleId IdType="pubmed">23295352</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XN, Song ZG, Jiang T, Shi BS, Hu YW, Yuan ZH. Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection. World J Gastroenterol. 2010;16:201&#x2013;209. doi: 10.3748/wjg.v16.i2.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v16.i2.201</ArticleId><ArticleId IdType="pmc">PMC2806558</ArticleId><ArticleId IdType="pubmed">20066739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Q, He F, Kwang J. Recent progress towards novel EV71 anti-therapeutics and vaccines. Viruses. 2015;7:6441&#x2013;6457. doi: 10.3390/v7122949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122949</ArticleId><ArticleId IdType="pmc">PMC4690872</ArticleId><ArticleId IdType="pubmed">26670245</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios G, Oberste MS. Enteroviruses as agents of emerging infectious diseases. J Neuro-Oncol. 2005;11:424&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">16287683</ArticleId></ArticleIdList></Reference><Reference><Citation>Granato M, Rizzello C, Gilardini MM, Cuomo L, Vitillo M, Santarelli R, Gonnella R, D'Orazi G, Faggioni A, Cirone M. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways. J Nutr Biochem. 2017;41:124&#x2013;136. doi: 10.1016/j.jnutbio.2016.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2016.12.011</ArticleId><ArticleId IdType="pubmed">28092744</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul TN, Middleton EJ, Ogra PL. Antiviral effect of flavonoids on human viruses. J Med Virol. 1985;15:71&#x2013;79. doi: 10.1002/jmv.1890150110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890150110</ArticleId><ArticleId IdType="pubmed">2981979</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas A, Del CJ, Clement S, Lemasson M, Garcia-Valdecasas M, Gil-Gomez A, Ranchal I, Bartosch B, Bautista JD, Rosenberg AR, Negro F, Romero-Gomez M. Effect of quercetin on hepatitis C virus life cycle: from viral to host targets. Sci Rep. 2016;6:31777. doi: 10.1038/srep31777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31777</ArticleId><ArticleId IdType="pmc">PMC4992894</ArticleId><ArticleId IdType="pubmed">27546480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Z, Sun G, Guo W, Huang Y, Sun W, Zhao F, Hu K. Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines. Virol Sin. 2015;30:261&#x2013;268. doi: 10.1007/s12250-015-3584-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-015-3584-5</ArticleId><ArticleId IdType="pmc">PMC8200874</ArticleId><ArticleId IdType="pubmed">26268473</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiow KH, Phoon MC, Putti T, Tan BK, Chow VT. Evaluation of antiviral activities of Houttuynia cordata Thunb. Extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac J Trop Med. 2016;9:1&#x2013;7. doi: 10.1016/j.apjtm.2015.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apjtm.2015.12.002</ArticleId><ArticleId IdType="pmc">PMC7104935</ArticleId><ArticleId IdType="pubmed">26851778</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaidya B, Cho SY, Oh KS, Kim SH, Kim YO, Jeong EH, Nguyen TT, Kim SH, Kim IS, Kwon J, Kim D. Effectiveness of periodic treatment of quercetin against influenza a virus H1N1 through modulation of protein expression. J Agric Food Chem. 2016;64:4416&#x2013;4425. doi: 10.1021/acs.jafc.6b00148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.6b00148</ArticleId><ArticleId IdType="pubmed">27157719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji P, Chen C, Hu Y, Zhan Z, Pan W, Li R, Li E, Ge HM, Yang G. Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot and mouth disease. Biol Pharm Bull. 2015;38:1&#x2013;6. doi: 10.1248/bpb.b14-00357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b14-00357</ArticleId><ArticleId IdType="pubmed">25744451</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai FJ, Lin CW, Lai CC, Lan YC, Lai CH, Hung CH, Hsueh KC, Lin TH, Chang HC, Wan L, Sheu JJ, Lin YJ. Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins. Food Chem. 2011;128:312&#x2013;322. doi: 10.1016/j.foodchem.2011.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2011.03.022</ArticleId><ArticleId IdType="pubmed">25212137</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CY, Huang SC, Zhang Y, Lai ZR, Kung SH, Chang YS, Lin CW. Antiviral ability of Kalanchoe gracilis leaf extract against enterovirus 71 and Coxsackievirus A16. Evid Based Complement Alternat Med. 2012:503165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3361180</ArticleId><ArticleId IdType="pubmed">22666293</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ. Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27:493&#x2013;497.</Citation></Reference><Reference><Citation>Shang B, Deng C, Ye H, Xu W, Yuan Z, Shi PY, Zhang B. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. Antivir Res. 2013;97:198&#x2013;205. doi: 10.1016/j.antiviral.2012.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.010</ArticleId><ArticleId IdType="pubmed">23267829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan J, George S, Kusov Y, Perbandt M, Anemuller S, Mesters JR, Norder H, Coutard B, Lacroix C, Leyssen P, Neyts J, Hilgenfeld R. 3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses. J Virol. 2013;87:4339&#x2013;4351. doi: 10.1128/JVI.01123-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01123-12</ArticleId><ArticleId IdType="pmc">PMC3624371</ArticleId><ArticleId IdType="pubmed">23388726</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S, Wang J, Fan T, Qin B, Guo L, Lei X, Wang J, Wang M, Jin Q. Crystal structure of human enterovirus 71 3C protease. J Mol Biol. 2011;408:449&#x2013;461. doi: 10.1016/j.jmb.2011.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.03.007</ArticleId><ArticleId IdType="pmc">PMC7094522</ArticleId><ArticleId IdType="pubmed">21396941</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YJ, Chang YC, Hsiao NW, Hsieh JL, Wang CY, Kung SH, Tsai FJ, Lan YC, Lin CW. Fisetin and rutin as 3C protease inhibitors of enterovirus A71. J Virol Methods. 2012;182:93&#x2013;98. doi: 10.1016/j.jviromet.2012.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.03.020</ArticleId><ArticleId IdType="pubmed">22465253</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Wang Y, Qing J, Shu B, Cao L, Lou Z, Gong P, Sun Y, Yin Z. An adenosine nucleoside analogue NITD008 inhibits EV71 proliferation. Antivir Res. 2014;112:47&#x2013;58. doi: 10.1016/j.antiviral.2014.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.10.009</ArticleId><ArticleId IdType="pubmed">25446894</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kung SH, Hsu YY, Liu WT. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J Gen Virol. 2002;83:1367&#x2013;1376. doi: 10.1099/0022-1317-83-6-1367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-6-1367</ArticleId><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Shih SR. Strategies to develop antivirals against enterovirus 71. Virol J. 2013;10:28. doi: 10.1186/1743-422X-10-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-28</ArticleId><ArticleId IdType="pmc">PMC3614426</ArticleId><ArticleId IdType="pubmed">23339605</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zou G, Xia A, Wang X, Cai J, Gao Q, Yuan S, He G, Zhang S, Zeng M, Altmeyer R. Enterovirus 71 infection in children with hand, foot, and mouth disease in shanghai, China: epidemiology, clinical feature and diagnosis. Virol J. 2015;12:83. doi: 10.1186/s12985-015-0308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0308-2</ArticleId><ArticleId IdType="pmc">PMC4464242</ArticleId><ArticleId IdType="pubmed">26036928</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PN, Shih SR. Update on enterovirus 71 infection. Curr Opin Virol. 2014;5:98&#x2013;104. doi: 10.1016/j.coviro.2014.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.03.007</ArticleId><ArticleId IdType="pubmed">24727707</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya Y, Shimizu M, Hiyama Y, Itoh K, Hashimoto Y, Nakayama M, Horie T, Morita N. Antiviral activity of natural occurring flavonoids in vitro. Chem Pharm Bull. 1985;33:3881&#x2013;3886. doi: 10.1248/cpb.33.3881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/cpb.33.3881</ArticleId><ArticleId IdType="pubmed">4092287</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, Chen CC, Stollar V, Shih SR. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293:386&#x2013;395. doi: 10.1006/viro.2001.1310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1310</ArticleId><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TT, Woo HJ, Kang HK, Nguyen VD, Kim YM, Kim DW, Ahn SA, Xia Y, Kim D. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol Lett. 2012;34:831&#x2013;838. doi: 10.1007/s10529-011-0845-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10529-011-0845-8</ArticleId><ArticleId IdType="pmc">PMC7087583</ArticleId><ArticleId IdType="pubmed">22350287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K, Nakane H, Fukushima M, Chermann JC, Barre-Sinoussi F. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem. 1990;190:469&#x2013;476. doi: 10.1111/j.1432-1033.1990.tb15597.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1990.tb15597.x</ArticleId><ArticleId IdType="pubmed">1695572</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Su H, Zhang T, Du J, Cui S, Yang F, Jin Q. Inhibition of enterovirus 71 replication by 7-hydroxyflavone and diisopropyl-flavon7-yl phosphate. PLoS One. 2014;9:e92565. doi: 10.1371/journal.pone.0092565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092565</ArticleId><ArticleId IdType="pmc">PMC3963929</ArticleId><ArticleId IdType="pubmed">24664133</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhang T, Du J, Cui S, Yang F, Jin Q. Anti-enterovirus 71 effects of chrysin and its phosphate ester. PLoS One. 2014;9:e89668. doi: 10.1371/journal.pone.0089668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089668</ArticleId><ArticleId IdType="pmc">PMC3943725</ArticleId><ArticleId IdType="pubmed">24598537</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>